158 related articles for article (PubMed ID: 30602990)
1. Fibrinolytic proteins of normal pregnancy and pre-eclamptic patients in North West Nigeria.
Oladosu-Olayiwola O; Olawumi H; Babatunde A; Ijaiya M; Durotoye I; Biliaminu S; Ibraheem R
Afr Health Sci; 2018 Sep; 18(3):576-583. PubMed ID: 30602990
[TBL] [Abstract][Full Text] [Related]
2. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria.
Belo L; Santos-Silva A; Rumley A; Lowe G; Pereira-Leite L; Quintanilha A; Rebelo I
BJOG; 2002 Nov; 109(11):1250-5. PubMed ID: 12452463
[TBL] [Abstract][Full Text] [Related]
3. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis as a Causative Mechanism for Bleeding Complications on Extracorporeal Membrane Oxygenation: A Pilot Observational Prospective Study.
Helms J; Curtiaud A; Severac F; Tschirhart M; Merdji H; Bourdin M; Contant G; Depasse F; Abou Rjeily R; Sattler L; Meziani F; Angles-Cano E
Anesthesiology; 2024 Jul; 141(1):75-86. PubMed ID: 38502917
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; PatrÃcio B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
Guler N; Burleson A; Syed D; Banos A; Hopkinson W; Hoppensteadt D; Rees H; Fareed J
Clin Appl Thromb Hemost; 2016 May; 22(4):372-6. PubMed ID: 26207021
[TBL] [Abstract][Full Text] [Related]
7. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.
Halligan A; Bonnar J; Sheppard B; Darling M; Walshe J
Br J Obstet Gynaecol; 1994 Jun; 101(6):488-92. PubMed ID: 8018635
[TBL] [Abstract][Full Text] [Related]
8. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
9. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
[TBL] [Abstract][Full Text] [Related]
10. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
DeSouza CA; Jones PP; Seals DR
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia.
Cadroy Y; Grandjean H; Pichon J; Desprats R; Berrebi A; Fournié A; Boneu B
Br J Obstet Gynaecol; 1993 May; 100(5):416-20. PubMed ID: 8518239
[TBL] [Abstract][Full Text] [Related]
12. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders.
Sartori MT; Serena A; Saggiorato G; Campei S; Faggian D; Pagnan A; Paternoster DM
J Thromb Haemost; 2008 Feb; 6(2):352-8. PubMed ID: 18021302
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty Patients.
Burleson A; Guler N; Banos A; Syed D; Wanderling C; Hoppensteadt D; Rees H; Fareed J; Hopkinson W
Clin Appl Thromb Hemost; 2016 Apr; 22(3):274-9. PubMed ID: 26460335
[TBL] [Abstract][Full Text] [Related]
14. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
Zuo Y; Warnock M; Harbaugh A; Yalavarthi S; Gockman K; Zuo M; Madison JA; Knight JS; Kanthi Y; Lawrence DA
Sci Rep; 2021 Jan; 11(1):1580. PubMed ID: 33452298
[TBL] [Abstract][Full Text] [Related]
15. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
McBane RD; Hardison RM; Sobel BE;
Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia.
Lucena FC; Lage EM; Teixeira PG; Barbosa AS; Diniz R; Lwaleed B; Talvani A; Alpoim PN; Perucci LO; Dusse LMS
Hypertens Pregnancy; 2019 Feb; 38(1):58-63. PubMed ID: 30760065
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia.
Koh SC; Anandakumar C; Montan S; Ratnam SS
Gynecol Obstet Invest; 1993; 35(4):214-21. PubMed ID: 8330765
[TBL] [Abstract][Full Text] [Related]
19. Association of pro-fibrinolytic receptor AnnexinA2 with tissue plasminogen activator/Inhibitor-1 in pre-eclampsia.
Ruikar K; Khode V; Shetty SS; Sarathkumar E; Patil P; Patil S; Bargale A; Sadashiv R; Shetty P
Afr Health Sci; 2023 Mar; 23(1):309-319. PubMed ID: 37545924
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
Wu WD; Xu YH; Tan PY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
